A Randomized, Two-Way Crossover, Single-Dose Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product (Nexium Powder for Injection and Infusion 40 mg) in Healthy Adult Subjects
To assess the bioequivalence of esomeprazole of the TEST product vs. the REFERENCE product in healthy volunteers who reside in Taiwan.
100 Clinical Results associated with isRed Pharma & Biotech Research Co.,Ltd.
0 Patents (Medical) associated with isRed Pharma & Biotech Research Co.,Ltd.
100 Deals associated with isRed Pharma & Biotech Research Co.,Ltd.
100 Translational Medicine associated with isRed Pharma & Biotech Research Co.,Ltd.